Disease/Infection News

RSS

College campuses at risk of becoming COVID-19 superspreaders, study shows

College campuses are at risk of becoming COVID-19 superspreaders for their entire county, according to a new vast study which shows the striking danger of the first two weeks of school in particular.

13 Jan 2021

Could fenofibrate be an effective antiviral against SARS-CoV-2?

The resurgence of COVID-19 pandemic, caused by the SARS-CoV-2, has led to renewed efforts to find effective antivirals, both newly developed or repurposed drugs. A study reports the efficacy of the cholesterol-reducing drug fenofibrate in reducing infection rates of SARS-CoV-2 in cultured cells.

13 Jan 2021

Study summarizes effectiveness of cloth masks in protecting clinicians from COVID-19

A rapid, evidence-based review summarizes the effectiveness of cloth masks in protecting health care clinicians from respiratory viral infections, such as COVID-19. Nine studies were included in the review, and all but one were conducted prior to the COVID-19 pandemic.

13 Jan 2021

Mid-quarantine testing may increase compliance among college athletes without increasing risk

Catherine O'Neal, MD, Assistant Professor of Clinical Medicine at LSU Health New Orleans School of Medicine's branch campus in Baton Rouge, is a co-author of a paper reporting that shortening the length of quarantine due to COVID exposure when supported by mid-quarantine testing may increase compliance among college athletes without increasing risk.

13 Jan 2021

Study compares acceptance of HPV vaccine and meningococcal vaccine

New research from Boston Medical Center finds that using clear, unambiguous language when recommending HPV vaccination both increases vaccine acceptance and increases conversation efficiency while preserving patient satisfaction.

13 Jan 2021

New technology could protect against different coronavirus variants

The SARS-CoV-2 virus that is causing the COVID-19 pandemic is just one of many different viruses in the coronavirus family.

13 Jan 2021

SARS-CoV-2 may join the ranks of mild cold-causing coronaviruses

What is the endgame for SARS-CoV-2, the virus that is causing worldwide devastation? If it becomes endemic -- circulating in the general population -- and most people are exposed in childhood, SARS-CoV-2 may join the ranks of mild cold-causing coronaviruses that currently circulate in humans, according to a model developed by Emory and Penn State scientists.

13 Jan 2021

Lactating women should discuss risks and benefits of COVID-19 vaccination, says ABM

The Academy of Breastfeeding Medicine (ABM) does not recommend cessation of breastfeeding for individuals who are vaccinated against COVID-19.

13 Jan 2021

Medical institutions should support health care workers with COVID-19 infection, say experts

By mid-November, the Centers for Disease Control and Prevention had reported that 218,439 health care workers in the U.S. had been infected with COVID-19 -- a likely underestimate due to incomplete data from states.

13 Jan 2021

Study: 82% respondents ventilate more frequently to protect themselves from corona

Despite cold temperatures, the population counts on fresh air to avoid contracting the coronavirus. This is shown by the results of the 26th edition of the BfR-Corona-Monitor, a regular survey by the German Federal Institute for Risk Assessment (BfR). In all age groups, about four out of five respondents say they ventilate more frequently.

13 Jan 2021

Researchers develop novel antibody fragments against SARS coronavirus-2

An international research team led by the University of Bonn (Germany) has identified and further developed novel antibody fragments against the SARS coronavirus-2. These "nanobodies" are much smaller than the classic antibodies used to treat US President Donald Trump, for example.

13 Jan 2021

FAU researchers develop simplified, rapid SARS-CoV-2 detection protocol

To properly monitor and help curb the spread of COVID-19, several millions of diagnostic tests are required daily in just the United States alone.

13 Jan 2021

New publication describes DiosCURE’s multivalent single-chain antibodies to inactivate SARS-CoV-2

DiosCURE SE announced a publication in Science describing its core technology of multivalent single-chain antibodies with a unique molecular mode-of-action to inactivate SARS-CoV-2 virions. An international team led by scientists at the University of Bonn developed and characterized the lead candidates, which are exclusively licensed by DiosCURE.

13 Jan 2021

Study shows how neurons can become a target of SARS-CoV-2 infection

Using both mouse and human brain tissue, researchers at Yale School of Medicine have discovered that SARS-CoV-2 can directly infect the central nervous system and have begun to unravel some of the virus's effects on brain cells.

13 Jan 2021

Cardiovascular deaths unrelated to COVID-19 increased during the pandemic, study finds

As the number of COVID-19 infections continues to rise nationwide, more than 360,000 Americans have already died from the potentially deadly viral infection.

13 Jan 2021

Open-faced helmet contains pathogen-bearing droplets, reduces transmission to medical specialists

The risk of infection of COVID-19 is high for medical specialists who come in contact with symptomatic or asymptomatic patients.

13 Jan 2021

Study: Testing policies should vary based on demand to catch the most COVID-19 cases

With months to go in the mass rollout of COVID-19 vaccines, testing is still critical to control the surging pandemic.

13 Jan 2021

Antibody-Fc-mediated innate immunity shapes COVID-19 severity

A short paper that appeared recently on the preprint bioRxiv server pointed to a link between specific characteristics of anti-SARS-CoV-2 antibodies associated with the severity of COVID-19.

12 Jan 2021

Intranasal vaccination effectively reduces viral shedding of SARS-CoV-2 in monkeys

A new preprint that appeared on the bioRxiv server reports that intranasal vaccination with the D614G variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus monkeys reduces viral shedding. This is an experiment in non-human primates (NHP), and its extrapolation to humans is unclear as yet.

12 Jan 2021

Structure of SARS-CoV-2 cytoplasmic tail uncovered

The virus's cytosolic tail also interacts with the host cell to promote its entry into the endoplasmic reticulum (ER). A new study appearing on the bioRxiv preprint server elucidates the conformation of this region of the virus, which will help understand how its form is related to its function in viral entry.

12 Jan 2021

Disease/Infection News

College campuses at risk of becoming COVID-19 superspreaders, study shows

Could fenofibrate be an effective antiviral against SARS-CoV-2?

Study summarizes effectiveness of cloth masks in protecting clinicians from COVID-19

Mid-quarantine testing may increase compliance among college athletes without increasing risk

Study compares acceptance of HPV vaccine and meningococcal vaccine

New technology could protect against different coronavirus variants

SARS-CoV-2 may join the ranks of mild cold-causing coronaviruses

Lactating women should discuss risks and benefits of COVID-19 vaccination, says ABM

Medical institutions should support health care workers with COVID-19 infection, say experts

Study: 82% respondents ventilate more frequently to protect themselves from corona

Researchers develop novel antibody fragments against SARS coronavirus-2

FAU researchers develop simplified, rapid SARS-CoV-2 detection protocol

New publication describes DiosCURE’s multivalent single-chain antibodies to inactivate SARS-CoV-2

Study shows how neurons can become a target of SARS-CoV-2 infection

Cardiovascular deaths unrelated to COVID-19 increased during the pandemic, study finds

Open-faced helmet contains pathogen-bearing droplets, reduces transmission to medical specialists

Study: Testing policies should vary based on demand to catch the most COVID-19 cases

Antibody-Fc-mediated innate immunity shapes COVID-19 severity

Intranasal vaccination effectively reduces viral shedding of SARS-CoV-2 in monkeys

Structure of SARS-CoV-2 cytoplasmic tail uncovered

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News